Industry News
Pharmaceutical Industry News
No go for Zosano as FDA knockback triggers suspension of transdermal migraine patch program
No go for Zosano as FDA knockback triggers suspension of transdermal migraine patch program ntaylor Tue, 05/03/2022 - 10:45
Bexson expands on-body ketamine delivery work into mental health
Bexson expands on-body ketamine delivery work into mental health ntaylor Tue, 05/03/2022 - 10:39
Biogen sends CEO to the exit, abandons Aduhelm sales team in $1B overhaul
Biogen sends CEO to the exit, abandons Aduhelm sales team in $1B overhaul aliu Tue, 05/03/2022 - 09:46
AstraZeneca sues Mylan after securing fresh delivery patent on Symbicort
AstraZeneca sues Mylan after securing fresh delivery patent on Symbicort ntaylor Tue, 05/03/2022 - 09:35
Opiant beats path to FDA after nasal overdose drug matches Narcan
Opiant beats path to FDA after nasal overdose drug matches Narcan ntaylor Tue, 05/03/2022 - 09:27
Bayer taps celebrity designers Nate Berkus and Jeremiah Brent for Claritin backyard makeover contest
Bayer taps celebrity designers Nate Berkus and Jeremiah Brent for Claritin backyard makeover contest nmissakian Tue, 05/03/2022 - 09:21
Novartis’ Netflix moment? Big Pharma launches new on-demand video hub to boost digital engagement with doctors
Novartis’ Netflix moment? Big Pharma launches new on-demand video hub to boost digital engagement with doctors badams Tue, 05/03/2022 - 09:20
CordenPharma, part of Germany’s mRNA contingency plan, sold to private equity outfit Astorg
CordenPharma, part of Germany's mRNA contingency plan, sold to private equity outfit Astorg fkansteiner Tue, 05/03/2022 - 09:19
FDA spurns Coherus and Junshi’s China-made PD-1 cancer drug
FDA spurns Coherus and Junshi's China-made PD-1 cancer drug fkansteiner Tue, 05/03/2022 - 08:06
Boehringer Ingelheim encourages women to ‘hear their heart’
Boehringer Ingelheim encourages women to 'hear their heart' sharon.coey Tue, 05/03/2022 - 07:53
GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in conviction
GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in conviction aliu Tue, 05/03/2022 - 07:10
4% success? Pharma’s ‘conservative nature’ dooms digital product launches, report finds
4% success? Pharma's 'conservative nature' dooms digital product launches, report finds badams Tue, 05/03/2022 - 05:48
Tennessee Halts Executions After Failing to Test Lethal Injection Drugs
Five men scheduled for execution this year were granted temporary reprieves while the state investigates why the drugs had not been tested for toxins.
Teva settlement prevents Lupin from launching its Austedo generic until 2033
Teva settlement prevents Lupin from launching its Austedo generic until 2033 kdunleavy Mon, 05/02/2022 - 15:04
With FDA approval, Supernus’ Qelbree is the first nonstimulant ADHD med for adults in 2 decades
With FDA approval, Supernus' Qelbree is the first nonstimulant ADHD med for adults in 2 decades zbecker Mon, 05/02/2022 - 12:34
Emergent mourns passing of founder and former CEO El-Hibri just one month after his retirement
Emergent mourns passing of founder and former CEO El-Hibri just one month after his retirement fkansteiner Mon, 05/02/2022 - 10:53
Bayer investors reject management compensation for 2021 but back company’s overall performance
Bayer investors reject management compensation for 2021 but back company's overall performance kdunleavy Mon, 05/02/2022 - 10:48
FDA snubs another China-made cancer drug, foiling Hutchmed’s first shot at US market
FDA snubs another China-made cancer drug, foiling Hutchmed's first shot at US market aliu Mon, 05/02/2022 - 10:13
Paxlovid’s post-exposure protection flop hardly spells the end for Pfizer’s COVID franchise: analysts
Paxlovid's post-exposure protection flop hardly spells the end for Pfizer's COVID franchise: analysts fkansteiner Mon, 05/02/2022 - 09:13
Orphalan pushes first drug for Wilson’s disease in 5 decades over FDA finish line
Orphalan pushes first drug for Wilson's disease in 5 decades over FDA finish line kdunleavy Mon, 05/02/2022 - 07:57